Friday morning snapshot

A snapshot of the early morning's equity news and key market movements.

London bus passing the Bank of England
Source: Bloomberg

Last night in the US: The Dow Jones closed down 161 points at 16,976, the NASDAQ finished down 62 points at 4363 and the S&P 500 ended the day down 23 points at 1958.

This morning in London: The FTSE 100 is currently down 25 points at 6712.

FX and commodities: GBP/USD is up 2 pips at $1.7101, EUR/USD is up 2 pips at $1.3527 and USD/JPY is up 25 pips at ¥101.45. Brent crude is up 35 cents at $108.32 and gold is trading at $1313, down $5.75.

Stocks: The airline sector is likely to struggle today as the implications of yesterday’s events unwind. The deal between Shire and US AbbVie looks ever closer to completion. UK banks Lloyds and RBS, face further investigation that might lead to recommendations for both banks to be broken up. GlaxoSmithKline looks set for more bad publicity as Chinese authorities unearth more details of the company’s distribution business.

The day ahead: UK eurozone current account figures are out this morning along with German Bupa president Jens Weidmann talking around midday. This afternoon will see preliminary University of Michigan consumer sentiment figures and the monthly Conference Board Leading Index.

All figures correct at 9am. All times London time.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.